A chromosomal breakage syndrome with profound immunodeficiency

Area of Science:

• Genetics
• Immunology
• Oncology

Background:

• Chromosomal breakage syndromes (CBS) like ataxia-telangiectasia, Fanconi's anemia, and Bloom's syndrome are linked to growth failure, neurological issues, immunodeficiency, and increased cancer risk.
• The exact relationship between these clinical features and the underlying genetic instability remains unclear.

Observation:

• A 21-year-old female patient presented with severe chromosomal breakage, profound immunodeficiency, and significant growth failure, exceeding that typically seen in known CBS.
• Despite extensive chromosomal abnormalities and immune dysfunction, the patient remained free of malignancy at the time of evaluation.
• Lymphocyte cultures revealed marked reductions in B and T cell numbers and function, with specific fragile sites on chromosomes 7 and 14 frequently involved in breaks and rearrangements.

Findings:

• The identified fragile sites (7p13, 7q35, 14q11, 14q32) are critical regions for T cell receptor and immunoglobulin heavy chain gene rearrangements during lymphocyte development.
• Both T cell mitogen-stimulated lymphocytes and Epstein-Barr virus-stimulated B cells/fibroblasts showed high rates of chromosomal breakage, though with less site specificity in the latter.

Implications:

• The specific localization of chromosomal fragility at gene rearrangement sites suggests a potential mechanism contributing to the pathogenesis of CBS.
• These findings may indicate that factors beyond the degree of immunodeficiency or chromosomal damage severity influence malignancy development in CBS.
• Further research into these specific fragile sites could offer insights into disease mechanisms and potential therapeutic targets for chromosomal breakage syndromes.